GIM
REGN icon

Guild Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Guild Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-16,360
Closed -$5.12M – 60
2013
Q3 		$5.12M Buy
+16,360
New +$4.3M 6.25% 2

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Guild Investment Management's REGN Position: Q4 2013 in Review

Guild Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2013, closing a stake of 16,360 shares — an estimated $5.12M sold.

Guild Investment Management first reported a position in REGN in Q3 2013 and held it in 1 quarter. The position peaked at $5.12M in Q3 2013. 438 funds tracked by Wall St. Rank hold REGN as of Q4 2013.

  • Guild Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Guild Investment Management sold 16,360 Regeneron Pharmaceuticals shares in Q4 2013, an estimated $5.12M.
  • Guild Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Guild Investment Management's Regeneron Pharmaceuticals position peaked at $5.12M in Q3 2013.
  • 438 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2013.

Based on Guild Investment Management's 13F filing for Q4 2013, filed 31 Jan 2014.